Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines

Title
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines
Authors
Keywords
Radiation resistance, Head and neck cancer, Kinase inhibitors, STAT5, STAT6
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 133
Publisher
Springer Nature
Online
2013-11-06
DOI
10.1186/1476-4598-12-133

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now